Compare Colgate-Palmolive Company (CL) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Teladoc Health Inc — how do they compare? Colgate-Palmolive Company trades at $92.22 (market cap $74.26B), while Teladoc Health Inc trades at $6.85 (market cap $1.29B). The key difference: Colgate-Palmolive Company is far larger — about 57.6× Teladoc Health Inc's market cap, and Colgate-Palmolive Company pays a 2.28% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| CL | TDOC | |
|---|---|---|
Market Cap | $74.26B | $1.29B |
Sector | Consumer Staples | Health |
52-Week High | $99.14 | $9.72 |
52-Week Low | $74.98 | $4.47 |
Enterprise Value | $80.74B | $1.55B |
Dividend Yield | 2.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.27, up 0.29% on the day, with a bullish technical signal and consistent earnings beats. The company reported Q2 2026 EPS of $0.99, exceeding estimates, driven by strong margins and organic growth in emerging markets, though North American performance remains weak. Operating cash flow remains robust at $4.2 billion in 2025, supporting shareholder returns.
Outlook is mixed: valuation appears stretched with a P/E of 36.72, but analyst consensus targets $99.10. Risks include competitive pressures in North America and high debt levels. The stock offers a stable dividend, but growth concerns and insider selling warrant caution.
TDOC trades at $7.13, up 6.74% in the last session, but remains under pressure after a 28% drop in August 2026 due to a revenue miss and lowered guidance. The stock shows oversold technical signals with RSI near 24, while fundamentals reveal a net loss margin of -7.13% despite a gross margin of 68.97%. Recent news highlights multiple law firm investigations into securities claims, adding to investor uncertainty.
The outlook is cautious; analyst consensus is a hold with a $8.88 price target, but risks include ongoing losses, competitive pressures, and legal scrutiny. Upside depends on execution in integrated care, but near-term volatility is high.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
